600529 山东药玻
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.4148.46012.13510.70410.631
总资产报酬率 ROA (%)1.9946.8339.6928.5718.139
投入资产回报率 ROIC (%)2.2507.82011.1129.7189.369

边际利润分析
销售毛利率 (%)32.56333.31033.14929.27626.844
营业利润率 (%)19.83418.72922.68719.20816.982
息税前利润/营业总收入 (%)20.04318.20721.86918.34415.859
净利润/营业总收入 (%)16.50515.41419.22516.26114.766

收益指标分析
经营活动净收益/利润总额(%)108.113113.177100.130100.133104.360
价值变动净收益/利润总额(%)2.8443.2123.2504.5260.770
营业外收支净额/利润总额(%)-1.072-0.859-0.176-0.609-0.426

偿债能力分析
流动比率 (X)3.7883.7552.9893.2123.017
速动比率 (X)2.7522.6962.3502.6012.331
资产负债率 (%)17.36617.41521.02819.14720.748
带息债务/全部投入资本 (%)5.2005.0406.9457.7089.296
股东权益/带息债务 (%)1,791.4211,851.3001,318.1181,188.222967.571
股东权益/负债合计 (%)475.852474.216375.557422.288381.970
利息保障倍数 (X)47.892-50.118-28.126-24.536-15.102

营运能力分析
应收账款周转天数 (天)70.34674.48770.63769.48870.328
存货周转天数 (天)184.258179.435128.086120.805122.672